NEWS & EVENTS

Highlights from First Open Payments Data Set

Yesterday, CMS made the first round of Open Payment data sets publically available on its website. The goal of collecting and making the information available is to help everyone understand the relationship between the healthcare industry (e.g., pharmaceutical and medical device manufactures) and healthcare providers (such as physicians and teaching hospitals).

The data released represents the majority of transfers of value for half of last year (August 1 through December 31), the first reporting period mandated by the Affordable Care Act. Some of the information submitted is not available as CMS rejected a number of records for failing to meet its guidelines (see this previous alert).

To help the public and, by extension, the media understand the meaning behind the data, experts at MMIS, Inc. used our MediSpend Insight solution to analyze the information available. MediSpend Insight is a business management tool provided by MMIS to help life science customers manage and analyze internal business operations while ensuring compliance to state, federal, and global transparency laws. The following tables show high-level findings, such as the healthcare companies that reported the most transfer of values and the dollar amount.

What we provide in this post is just the tip of the data iceberg. Tim Robinson, Esq., our Chief Knowledge Officer and our MediSpend Analysts are available for comment while they continue to analyze this important data.

Notes on the following tables:

  • Analysis was conducted on 10/1/2014 using the currently published CMS data.
  • The data analyzed includes only the currently available data and does not include all data submitted by manufacturers to the Open Payments for program year 2013. Consult the Open Payments Data Dictionary document for an explanation of the criteria CMS used to determine which data to publish.
  • The data set includes only data that was successfully associated with specific physicians or teaching hospitals. Data that was not successfully associated with specific physicians or teaching hospitals will be analyzed in a future blog post.  

General Spend

Top 20 Manufacturers Reporting General Spend to Physicians and Organizations/Teaching Hospitals

(August 1, 2013 - December 31, 2013)

Rank Manufacturer Payments
1 Genentech, Inc. $130,065,012
2 DePuy Synthes Sales Inc. $35,560,618
3 Pfizer Inc. $20,512,546
4 Zimmer Holding Inc $17,282,065
5 AstraZeneca Pharmaceuticals LP $15,766,876
6 Arthrex, Inc. $15,506,504
7 Janssen Pharmaceuticals, Inc $14,470,504
8 Biomet, Inc. $13,861,371
9 Allergan Inc. $12,263,948
10 Smith & Nephew, Inc. $12,257,877
11 Otsuka America Pharmaceutical, Inc. $10,752,338
12 Forest Laboratories, Inc. $10,439,790
13 Boston Scientific Corporation $8,363,299
14 Stryker Corporation $8,360,991
15 Intuitive Surgical, Inc. $8,329,153
16 Takeda Pharmaceuticals U.S.A., Inc. $7,989,466
17 AbbVie, Inc. $7,971,558
18 Merck Sharp & Dohme Corporation $7,922,825
19 Boehringer Ingelheim Pharmaceuticals, Inc. $7,706,833
20 Eli Lilly and Company $7,189,853

 Research Payments 

Top 20 Manufacturers Who Made Research Payments to Physicians and Organizations/Teaching Hospitals

(August 1, 2013 - December 31, 2013)

Rank Manufacturer Amount
1 Bristol-Myers Squibb Company $17,973,563
2 Pfizer Inc. $15,516,294
3 GlaxoSmithKline, LLC. $14,933,034
4 Incyte Corporation $10,682,488
5 Merck Sharp & Dohme Corporation $10,093,436
6 Genentech, Inc. $7,673,512
7 Eli Lilly and Company $5,585,904
8 Millennium Pharmaceuticals, Inc. $5,447,722
9 Janssen Research & Development, LLC $4,534,708
10 Takeda Pharmaceuticals U.S.A., Inc. $3,803,519
11 Allergan Inc. $3,020,199
12 Sanofi and Genzyme US Companies $3,016,350
13 AstraZeneca Pharmaceuticals LP $3,011,648
14 Seattle Genetics, Inc. $2,639,115
15 Celgene Corporation $2,521,515
16 Actelion Pharmaceuticals US, Inc. $1,901,501
17 Otsuka America Pharmaceutical, Inc. $1,709,024
18 Novartis Pharmaceuticals Corporation $1,663,582
19 Bausch and Lomb Inc. $1,526,100
20 Forest Laboratories, Inc. $1,455,643

Research Payments

Top 20 Physicians Who Received Research Payments from Manufacturers

(August 1, 2013 - December 31, 2013)

Rank First Name Last Name Physician Primary Type Amount
1 STUART WINTER Medical Doctor $2,886,844
2 MONICA BERTAGNOLLI Medical Doctor $916,288
3 MICHAEL LANDZBERG Medical Doctor $851,388
4 IAN FLINN Medical Doctor $842,646
5 ZEID KAYALI Medical Doctor $764,742
6 THOMAS KING Medical Doctor $670,501
7 TERENCE HERMAN Medical Doctor $623,100
8 JAMES MCGEE Medical Doctor $582,392
9 FRANCES COLLICHIO Medical Doctor $564,034
10 PRIYA KUMTHEKAR Medical Doctor $447,310
11 CECELIA SHIKUMA Medical Doctor $433,925
12 RAJ MATURI Medical Doctor $416,168
13 CHRISTINE LU-EMERSON Medical Doctor $403,578
14 ROBERT FINE Medical Doctor $394,177
15 BRIAN SAMUELS Medical Doctor $384,216
16 WILLIAM WIERDA Medical Doctor $328,931
17 SUSAN CHANG Medical Doctor $314,319
18 JITENDRA GANDHI Medical Doctor $298,794
19 RAGINI KUDCHADKAR Medical Doctor $291,330
20 JEREMY FELDMAN Medical Doctor $286,255
Ownership and Investment Interest Information is defined as information about the value of ownership or investment interest in an applicable manufacturer or applicable group purchasing organization.

Ownership & Investment

Physician and Family Investment Interest Made by Manufacturers or GPOs

(August 1, 2014 – December 31, 2014)

Rank First Name Last Name Dollar Amount Invested Value of Interest as of 12/31/13
1 Elizabeth Baker $44,154,926.00 $41,580,000.00
2 Geoffrey Clark $43,581,486.00 $41,040,000.00
3 JOHN SIMPSON $19,696,874.52 $19,696,874.52
4 John Steinmann $11,555,957.83 $16,392,654.06
5 GREGORY ROBERTSON $4,401,641.58 $4,401,641.58
6 Frank Cammisa $4,163,812.00 $5,689,290.00
7 Nicholas Lembo $3,309,877.67 $3,309,877.67
8 George Suarez $3,280,715.54 $3,280,715.54
9 MARVIN SLEPIAN $2,705,380.81 $2,705,657.00
10 Paul Asdourian $2,617,970.61 $3,043,690.42
11 Nicole Orr $2,548,625.00 $2,400,000.00
12 Michael Hartman $2,479,917.25 $2,651,876.75
13 JOHN THALGOTT $2,315,852.00 $4,728,603.10
14 Jason Primer $2,268,482.27 $5,034,397.17
15 SCOTT LEARY $2,000,000.00 $3,326,750.00
16 James Berbee $1,750,000.00 $1,536,487.00
17 Steven Isenberg $1,699,350.75 $5,754,037.25
18 Anthony Yeung $1,571,918.00 $0.00
19 Eric Prystowsk $1,458,435.08 $1,458,435.08
20 Gail Hopkins $1,402,235.21 $1,595,835.29

Medispend Marketing


Posted on Oct 1, 2014 12:12:06 PM

Share This Story, Choose Your Platform!

SUBSCRIBE

Want to stay updated on news and events?

SUBSCRIBE

 

CONTACT US

Want to learn more about how our solutions can help your company?

LEARN MORE